» Articles » PMID: 17384640

Mitochondrial Aspartyl-tRNA Synthetase Deficiency Causes Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation

Abstract

Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) has recently been defined based on a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy. LBSL is an autosomal recessive disease, most often manifesting in early childhood. Affected individuals develop slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. We performed linkage mapping with microsatellite markers in LBSL families and found a candidate region on chromosome 1, which we narrowed by means of shared haplotypes. Sequencing of genes in this candidate region uncovered mutations in DARS2, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals from all 30 families. Enzyme activities of mutant proteins were decreased. We were surprised to find that activities of mitochondrial complexes from fibroblasts and lymphoblasts derived from affected individuals were normal, as determined by different assays.

Citing Articles

Loss of an uncharacterized mitochondrial methionine tRNA-synthetase induces mitochondrial unfolded protein response in .

Thapa B, Das M, Held J, Patel M bioRxiv. 2025; .

PMID: 39975410 PMC: 11838591. DOI: 10.1101/2025.02.03.636310.


Diagnosis of hereditary ataxias: a real-world single center experience.

Meli A, Montano V, Palermo G, Fogli A, Rocchi A, Gerfo A J Neurol. 2025; 272(2):111.

PMID: 39812846 DOI: 10.1007/s00415-024-12772-9.


Simultaneous determination of cytosolic aminoacyl-tRNA synthetase activities by LC-MS/MS.

Mendes M, Wolf N, Rudinger-Thirion J, Lenz D, Frugier M, Verloo P Nucleic Acids Res. 2024; 52(22):e107.

PMID: 39574415 PMC: 11662674. DOI: 10.1093/nar/gkae1134.


Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition.

Del Prado L, Jaraiz-Rodriguez M, Agro M, Zamora-Dorta M, Azpiazu N, Calleja M Nat Commun. 2024; 15(1):8682.

PMID: 39375345 PMC: 11458614. DOI: 10.1038/s41467-024-52968-1.


Targeted degradation of extracellular mitochondrial aspartyl-tRNA synthetase modulates immune responses.

Johnson B, Farkas D, El-Mergawy R, Adair J, Elhance A, Eltobgy M Nat Commun. 2024; 15(1):6172.

PMID: 39039092 PMC: 11263397. DOI: 10.1038/s41467-024-50031-7.